Analyst ratings
10 analysts have weighed in: a Strong Buy consensus: 10 buy calls against 0 sell, with an average 12-month price target of $32.40.
NASDAQ: UNCY · Biotechnology
Over the past week, Unicycive Therapeutics (UNCY) logged 11 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 19% bullish but is at odds: News runs 38% bullish while Reddit sits at just 0%. Wall Street is more constructive, with 10 of 10 analysts rating UNCY a buy.
There is little buzz around UNCY this week and some agreement on direction, which is why it reads as a Sell.
Wall Street’s 100% buy share sits next to a crowd that ranges from Reddit at 0% to News at 38%. No other tracker puts the two side by side.
10 analysts have weighed in: a Strong Buy consensus: 10 buy calls against 0 sell, with an average 12-month price target of $32.40.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is mixed and the 2 sources disagree sharply, so the read is a Sell.
Analysts sit 81 points above the crowd average of 19%, the professionals are more constructive than retail. The split is inside the crowd: News reads 38% bullish while Reddit sits at 0%, a 38-point spread that single-source trackers miss.
Over the 30-day window, Unicycive Therapeutics (UNCY) buzz held subdued around 14.0 while the price drifted up 2.4% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 817K shares. Updated Aug 15, 2026. Over the last 7 trading days, UNCY gained 9.1%. Buzz activity in the recent week averaged 21.4 and was variable, swinging between 14.0 and 44.3. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment split evenly between bullish and bearish days, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No X data for this stock this week.
No Polymarket data for this stock this week.
Query sentiment for UNCY and 2000+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live UNCY sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Aug 15, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Strong Buy (10 / 0 / 0) |
| Crowd bullish (7d) | 19% |
| Avg price target | $32.40 |
| Most bullish source | News, 38% |
| Most bearish source | Reddit, 0% |
| Sentiment spread | 38 pts |
| Mentions (7d) | 11 |
| Market cap | $150.9M |
| P/E · Forward P/E | n/a · 3.4 |
| EPS · Beta | -$1.79 · 1.8 |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit and News sources, Unicycive Therapeutics (UNCY) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 19% bullish across 2 active sources. Those sources contribute 11 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Unicycive Therapeutics (UNCY) is fairly quiet with 3 mentions over the last 7 days; the 30-day context spans 1 tracked subreddits. The 7-day tone is 0% bullish; 3-day activity momentum is falling, suggesting cooling attention.
The crowd reads bearish on Unicycive Therapeutics (UNCY), averaging 19% bullish across 2 tracked sources over the last 7 days. The two ends of the range are News at 38% bullish and Reddit at 0%, a 38-point spread. On the professional side, 10 of 10 analysts rate UNCY a buy.
Of the 10 analysts covering Unicycive Therapeutics (UNCY), 10 rate it a buy, 0 a hold and 0 a sell, for a strong buy consensus. The average price target is $32.40. That puts the street ahead of the crowd, which averages 19% bullish.
Unicycive Therapeutics (UNCY)'s cross-source average is bearish at 19% bullish. All 2 tracked sources lean bearish. News reads 38% bullish and reddit coverage is the most negative at 0% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for Unicycive Therapeutics (UNCY) at 19% bullish. All 2 tracked sources lean bearish. The most bearish reading is reddit at 0% bullish. 3-day activity momentum is falling on Reddit, while news activity is rising. The sell signal carries 93/100 conviction.
News is the dominant discussion channel with 8 mentions (73% of total volume). Reddit contributes 3 mentions. The cross-source average is bearish at 19% bullish, while news is the only source with rising 3-day activity. All 2 tracked sources lean bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. UNCY's sell signal at 93/100 conviction reflects a bearish cross-source average at 19% bullish. All 2 tracked sources lean bearish. It is a research shortcut, not financial advice.
The UNCY sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key